What is Bharat Biotech's intra-nasal Covid-19 vaccine Incovacc
India approves its first nasal spray COVID-19 vaccine
Ocugen sniffs out COVID opportunity, landing nasal vaccine
Bharat Biotech's intranasal Covid vaccine gets approval
Bharat Biotech's nasal vaccine is heterologous booster
How is the Covaxin vaccine launched in August 15?
Why did WHO not approve Indian covaxin for covid-19?
How can Imran Khan get a free covid vaccine from India?
What is your views on Modi's speech on COVID19?
Why is covaxin priced higher than covishield?
What is your analysis of Modi's speech at Hyderabad today?
What is the alternative plan to vaccinate India?
Is Modi's visit to the US a success?
What is the latest update on Corona/Covid-19 in India
India approves its first nasal spray COVID-19 vaccine
What is Bharat Biotech's intra-nasal Covid-19 vaccine Incovacc
India approves its first nasal spray COVID-19 vaccine
Ocugen sniffs out COVID opportunity, landing nasal vaccine
Bharat Biotech's intranasal Covid vaccine gets approval
Bharat Biotech's nasal vaccine is heterologous booster
Bharat Biotech's nasal vaccine, called Covaxin, is an inactivated vaccine that is administered through the nose. It has several potential advantages as a vaccine
delivery method:
Convenient administration: Nasal vaccines are easier to administer than injectable vaccines, and do not require trained medical personnel to administer them. This makes them a more practical option for vaccination campaigns in resource-limited settings.
Better immune response: Nasal vaccines have been shown to induce a stronger immune response compared to injectable vaccines, particularly in the mucosal immune system (the immune system in the lining of the nose and respiratory tract). This is because the nasal mucosa is rich in immune cells that can respond to the vaccine.
Fewer side effects: Nasal vaccines generally have fewer side effects compared to injectable vaccines, particularly when it comes to local reactions at the injection site.
Non-invasive:
Nasal vaccines are non-invasive, which may make them more acceptable to some people who are hesitant to receive an injectable vaccine.
Overall, Bharat Biotech's nasal vaccine has the potential to be a practical and effective option for COVID-19 vaccination campaigns, particularly in resource-limited settings where convenient and easy-to-administer vaccines are needed.
Nasal vaccination is an attractive approach for several reasons. First, the nasal route of administration allows the vaccine to stimulate immune responses in the respiratory tract, which is the site of infection for many respiratory diseases. This can result in a more effective immune response compared to vaccines administered through other routes.
In addition, nasal vaccines are easier to administer than injectable vaccines, which require trained personnel and sterile needles. This makes them more accessible, especially in resource-limited settings. Nasal vaccines also have the potential to be self-administered, which could increase vaccine coverage and reduce the burden on healthcare systems.
For vaccine click here
Finally, nasal vaccines have the potential to be more cost-effective than injectable vaccines, as they do not require specialized equipment or trained personnel for administration.
It is worth noting that nasal vaccines are not suitable for all diseases and populations. For example, nasal vaccines may not be as effective at inducing an immune response in older adults, who have a less responsive immune system. In addition, nasal vaccines may not be suitable for individuals with certain allergies or sensitivities to the vaccine components.
All right resvered by Google
Thanking you all readers please be safe
And wear mask...
